AU5270499A - Formulations having probiotically active microorganisms - Google Patents

Formulations having probiotically active microorganisms

Info

Publication number
AU5270499A
AU5270499A AU52704/99A AU5270499A AU5270499A AU 5270499 A AU5270499 A AU 5270499A AU 52704/99 A AU52704/99 A AU 52704/99A AU 5270499 A AU5270499 A AU 5270499A AU 5270499 A AU5270499 A AU 5270499A
Authority
AU
Australia
Prior art keywords
formulations
active microorganisms
probiotically active
probiotically
microorganisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52704/99A
Inventor
Helmut Viernstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU5270499A publication Critical patent/AU5270499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04Preserving or maintaining viable microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AU52704/99A 1998-08-06 1999-07-29 Formulations having probiotically active microorganisms Abandoned AU5270499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0136098A AT407008B (en) 1998-08-06 1998-08-06 FORMULATIONS WITH PROBIOTALLY EFFECTIVE MICROORGANISMS
AT1360/98 1998-08-06
PCT/AT1999/000192 WO2000007571A2 (en) 1998-08-06 1999-07-29 Formulations having probiotically active microorganisms

Publications (1)

Publication Number Publication Date
AU5270499A true AU5270499A (en) 2000-02-28

Family

ID=3512210

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52704/99A Abandoned AU5270499A (en) 1998-08-06 1999-07-29 Formulations having probiotically active microorganisms

Country Status (4)

Country Link
EP (1) EP1102580A2 (en)
AT (1) AT407008B (en)
AU (1) AU5270499A (en)
WO (1) WO2000007571A2 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767203B2 (en) * 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
AU2001272369A1 (en) * 2000-07-17 2002-01-30 Chr. Hansen A/S Methods and formultations with probiotic microorganisms and medicaments
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
EP1287745A1 (en) 2001-08-24 2003-03-05 The Procter & Gamble Company Chewable compositions with probiotic agents
DE102006054260A1 (en) * 2006-02-28 2007-09-27 Lohmann Animal Health Gmbh & Co. Kg Water stabilizing composition, process for its preparation and its use
RU2560425C2 (en) * 2008-08-28 2015-08-20 Кр. Хансен А/С Stabiliser of colour in bacterial composition
EP2398890B1 (en) * 2009-02-23 2015-07-29 Chr. Hansen A/S Method for making lactid acid bacteria composition
FR2963239B1 (en) * 2010-08-02 2013-03-08 Vetalis SOLAR EFFERVESCENT GALENIC FORMS FOR ANIMALS
EP2600877A4 (en) 2010-08-04 2014-05-07 Borody Thomas J Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
TR201007613A2 (en) * 2010-09-16 2012-04-24 Yed�Tepe �N�Vers�Tes� Lyophilized biopesticide effervescent granules and production method
JP2014507481A (en) 2011-03-09 2014-03-27 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ Compositions and methods for colonic microbiota transplantation
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
CN103550401B (en) * 2013-11-19 2016-06-22 浙江美保龙生物技术有限公司 A kind of preparation method of composite microbial ecological agent effervescent tablet
AU2015245942A1 (en) * 2014-04-09 2016-10-20 Kambouris Shares Pty Ltd Methods and compositions for delivering a probiotic
KR102561989B1 (en) 2015-05-14 2023-07-31 핀치 테라퓨틱스 홀딩스 엘엘씨 Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
AU2016268158B2 (en) 2015-05-22 2022-03-17 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
CN110831606A (en) 2017-04-05 2020-02-21 克雷斯顿沃控股公司 Compositions and methods for treating Parkinson's Disease (PD) and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
EP3630190B1 (en) 2017-05-26 2024-02-21 Finch Therapeutics Holdings LLC Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
US11865145B2 (en) 2017-08-07 2024-01-09 Finch Therapeutics Holdings Llc Compositions and methods for maintaining and restoring a healthy gut barrier
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
US11911419B2 (en) 2018-09-27 2024-02-27 Finch Therapeutics Holdings Llc Compositions and methods for treating epilepsy and related disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1061894A (en) * 1963-03-01 1967-03-15 Lucien Nouvel Therapeutically active bacterial preparations
FR3626M (en) * 1963-11-13 1965-10-18 Lucien Nouvel Medicine for intestinal complaints.
FI840816A0 (en) * 1984-03-01 1984-03-01 Farmos Oy BAKTERIEPREPARAT
EP0203586A3 (en) * 1985-05-29 1988-03-09 Pioneer Hi-Bred International A composition for treating gastrointestinal disease in animals
GB8908361D0 (en) * 1989-04-13 1989-06-01 Beecham Group Plc Composition
DE4033996A1 (en) * 1990-10-25 1992-04-30 Karl Heinz Hoelzel Capsules for normalising intestinal flora - contg. freeze-dried Lactobacillus and Bifidobacterium cultures
US5340577A (en) * 1992-07-29 1994-08-23 The United States Of America, As Represented By The Secretary Of Agriculture Probiotic for control of salmonella
CA2156859A1 (en) * 1993-02-24 1994-09-01 Sherwood L. Gorbach Method of enhancing immune response to oral vaccines
US5785990A (en) * 1995-07-10 1998-07-28 Merrick's, Inc. Feed fortifier and enhancer for preruminant calves and method of using same
AT405235B (en) * 1995-11-02 1999-06-25 Helmut Dr Viernstein PROBIOTALLY EFFECTIVE FORMULATION
FR2770778B1 (en) * 1997-11-12 2000-05-26 Investigations Therapeutiques COMPOSITION FOR THE TREATMENT OF ACUTE GASTROENTERITIS, MANUFACTURING METHOD THEREOF AND TREATMENT SOLUTION OBTAINED FROM THIS COMPOSITION

Also Published As

Publication number Publication date
WO2000007571A2 (en) 2000-02-17
EP1102580A2 (en) 2001-05-30
AT407008B (en) 2000-11-27
WO2000007571A3 (en) 2000-05-11
ATA136098A (en) 2000-04-15

Similar Documents

Publication Publication Date Title
AU5270499A (en) Formulations having probiotically active microorganisms
AUPP427398A0 (en) Improved disinfection
AU1916599A (en) Sachet formulations
AU2215495A (en) Enzymatic antimicrobial compositions
AU1433299A (en) Disinfecting agent
AU1878601A (en) Enzyme
AU6604598A (en) Farm implement
AU1412400A (en) Hydrophilic member
AU6763198A (en) Stabilized solid bacteria compositions
AU1969800A (en) Combination of active agents
AU5965399A (en) Pharmaceutically active composition
AU1560200A (en) Disinfecting agents
AU2656799A (en) Metal-thiols as imminomodulating agents
AU7432698A (en) Disinfectant composition
AU4064699A (en) Insecticide
AUPP715098A0 (en) Cultivator point assembly
AU3740499A (en) Agricultural adjuvant
AU2713300A (en) Stable aqueous enzyme compositions
AU3538699A (en) Novel physiologically active substances
AU4031299A (en) Perfumes comprising 4-isobutylcyclohexanols
AU4384497A (en) Insect-repellent formulations
AU1649700A (en) Novel formulation
AU2647099A (en) Active splitter
AU2648999A (en) Absorbent
AU4521599A (en) Germicidal composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase